Metalert, INC
Market Movers (8-K)
OTC.Pink
MLRT
Metalert, INCMetAlert, Inc. has issued a pre-funded common stock purchase warrant to Carl LaRue as part of a larger securities purchase agreement.
Capital raise
OTC.Pink
MLRT
Metalert, INCMetAlert Inc. has announced the resignation of its independent auditor, M&K CPAS, and the appointment of DBBM as its new auditor, effective July 12, 2024.
Quarterly Earnings (10-Q)
OTC.Pink
MLRT
Metalert, INCMetAlert, Inc. reported a 28% revenue decrease in Q2 2025 and a significant cash reduction, raising substantial doubt about its ability to continue as a going concern.
Delay expected
Worse than expected
Capital raise
OTC.Pink
MLRT
Metalert, INCMetAlert, Inc. reported a 16% decrease in Q1 2025 revenues and a worsening working capital deficit, leading to substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
Delay expected
OTC.Pink
MLRT
Metalert, INCMetAlert Inc. experienced a 39% decrease in revenue for the third quarter of 2024 due to production delays, despite positive trends in international subscriptions and direct-to-consumer sales.
Worse than expected
Delay expected
Capital raise
OTC.Pink
MLRT
Metalert, INCMetAlert Inc. experienced a decrease in revenue in Q2 2024 compared to Q2 2023, as the company transitions its focus from direct-to-consumer sales to a B2B model and introduces new product lines.
Worse than expected
Capital raise
OTC.Pink
MLRT
Metalert, INCMetAlert Inc. experienced a 34% decrease in revenue in Q1 2024 compared to Q1 2023, primarily due to a transition from direct-to-consumer PPE sales to a B2B model and the introduction of new products.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
OTC.Pink
MLRT
Metalert, INCMetAlert Inc.'s 2024 annual report reveals a year of strategic shifts, including an acquisition and product line expansion, amidst ongoing financial difficulties and a going concern warning.
Capital raise
Worse than expected
OTC.Pink
MLRT
Metalert, INCMetAlert Inc. reports its full year 2023 results, including a strategic acquisition and progress in product development and market expansion, while also noting ongoing financial challenges.
Delay expected
Capital raise
Worse than expected